Search
for
Sort by
Research 301–330 of 474
- The Use of 308-nm Excimer Laser Therapy in Alopecia Areata and Primary Cicatricial Alopecia: A Systematic Review
- 153 Effectiveness of OR-101, a next generation highly selective JAK3 inhibitor, in a humanized murine model of alopecia areata
- 022 Exploring the potential of the novel IFNγ aptamer TAGX-0003 as a treatment for alopeciaareata in pre-clinical models
- Association of JAK 1 and JAK 2 gene polymorphism with alopecia areata risk: a case–control genetic study
- New Modalities in the Treatment of Refractory Alopecia Areata
- Evaluation of the efficacy of topical metformin 10% and 20% versus topical potent steroid in the treatment of patients with alopecia areata
- A Real-World Study of Steroid-Free Monotherapy with Tofacitinib in Severe and Therapy-Recalcitrant Alopecia Areata, Alopecia Totalis, and Alopecia Universalis Cases: A Retrospective Analysis
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
- Reversal of alopecia areata, osteoporosis follow treatment with activation of Tgr5 in mice
- Tru9I Variant as a Novel Genetic Marker for Vitamin D Deficiency in Alopecia Areata
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Immune therapies for alopecia areata: evidence and new perspectives
- AIRE Deficiency Leads to the Development of Alopecia Areata‒Like Lesions in Mice
- Safety and efficacy of tofacitinib in 97 alopecia areata patients
- Alopecia areata susceptibility variant in MHC region impacts expressions of genes contributing to hair keratinization and is involved in hair loss
- Alopecia areata: What’s new in the epidemiology, comorbidities, and pathogenesis?
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Case report: Sequential therapy with dupilumab and baricitinib for severe alopecia areata with atopic dermatitis in children
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- Janus kinase inhibitors for alopecia areata: A narrative review
- Tofacitinib (Selective Janus Kinase Inhibitor 1 and 3): A promising therapy for the treatment of alopecia areata: A case report of six patients
- IL-12/IL-23 neutralization is ineffective for alopecia areata in mice and humans
- Cancer risk in patients with alopecia areata: a nationwide population‐based matched cohort study
- Dietary Habits in Japanese Patients with Alopecia Areata
- Correlation between increased total serum IgE levels and clinical features in alopecia areata patients
- Role of Aire and Notch4 Allelic Mutations in Alopecia Areata in C3H/HeJ Mice
- Upadacitinib: A New Weapon for the Treatment of Twenty-Nail Dystrophy
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- The efficacy and safety of JAK inhibitors for alopecia areata: A systematic review and meta-analysis of prospective studies